Published in Neurotherapeutics on July 01, 2015
Trial of RAD001 and Neurocognition in Tuberous Sclerosis Complex (TSC) (TSC) | NCT01289912
Rapalogues for Autism Phenotype in TSC: A Feasibility Study (RAPT) | NCT01929642
Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC) | NCT01780441
Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSC | NCT01767779
Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference. Pediatr Neurol (2016) 0.87
Symptom profiles of autism spectrum disorder in tuberous sclerosis complex. Neurology (2016) 0.78
Defective phosphoinositide metabolism in autism. J Neurosci Res (2016) 0.76
Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Mol Brain (2016) 0.76
Genetic Syndromes, Maternal Diseases and Antenatal Factors Associated with Autism Spectrum Disorders (ASD). Front Neurosci (2016) 0.76
Therapeutic Advances in Autism and Other Neurodevelopmental Disorders. Neurotherapeutics (2015) 0.75
mTOR signaling in growth control and disease. Cell (2012) 29.21
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med (2008) 9.64
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med (2010) 8.28
Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol (2007) 6.96
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med (2011) 6.74
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol (2008) 5.55
Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med (2008) 5.15
mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci (2009) 5.04
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol (2006) 4.24
Tuberous sclerosis. Lancet (2008) 4.24
Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature (2011) 4.13
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat Neurosci (2005) 4.00
The autistic neuron: troubled translation? Cell (2008) 3.81
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci (2008) 3.64
A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci (2007) 3.51
Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol (2002) 3.37
Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol (2013) 3.18
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature (2012) 3.12
Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression. J Neurosci (2004) 3.04
Epidemiology of tuberous sclerosis. Ann N Y Acad Sci (1991) 2.96
Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron (2014) 2.44
Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 2.22
Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial. Clin Cancer Res (2011) 2.06
Randomized trial of vigabatrin in patients with infantile spasms. Neurology (2001) 1.96
Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet (2009) 1.79
Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain (2002) 1.75
Everolimus for subependymal giant cell astrocytoma in patients with tuberous sclerosis complex: 2-year open-label extension of the randomised EXIST-1 study. Lancet Oncol (2014) 1.74
Everolimus alters white matter diffusion in tuberous sclerosis complex. Neurology (2012) 1.73
Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci (2009) 1.67
Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology (2007) 1.64
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A (2011) 1.58
Distortions and disconnections: disrupted brain connectivity in autism. Brain Cogn (2010) 1.57
Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol (2007) 1.54
The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLoS One (2012) 1.53
Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum Mol Genet (2010) 1.53
Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One (2011) 1.48
The neurology of mTOR. Neuron (2014) 1.43
Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex. Eur J Paediatr Neurol (2011) 1.39
Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomized, prospective study. Epilepsia (1997) 1.38
Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis (2011) 1.38
Excitatory/inhibitory synaptic imbalance leads to hippocampal hyperexcitability in mouse models of tuberous sclerosis. Neuron (2013) 1.37
Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2007) 1.37
Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Res (1997) 1.37
Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma. Neurology (2013) 1.33
Vigabatrin: 2008 update. Epilepsia (2009) 1.31
Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell (2011) 1.31
Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex. Acad Radiol (2012) 1.26
Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia (1999) 1.23
Early control of seizures improves long-term outcome in children with tuberous sclerosis complex. Eur J Paediatr Neurol (2009) 1.22
Rapamycin reduces seizure frequency in tuberous sclerosis complex. J Child Neurol (2009) 1.22
Immune dysfunction in autism: a pathway to treatment. Neurotherapeutics (2010) 1.22
Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review. J Child Neurol (1999) 1.18
Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity. BMC Med (2013) 1.17
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex. Ann Clin Psychiatry (2011) 1.15
Gestational immune activation and Tsc2 haploinsufficiency cooperate to disrupt fetal survival and may perturb social behavior in adult mice. Mol Psychiatry (2010) 1.15
Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol (2006) 1.15
Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex. J Pediatr (2014) 1.14
Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol (2008) 1.14
Autism and the cerebellum: evidence from tuberous sclerosis. J Autism Dev Disord (2000) 1.12
Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy. Pediatr Neurol (2014) 1.12
Evolving neurobiology of tuberous sclerosis complex. Acta Neuropathol (2013) 1.11
Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach. Dev Med Child Neurol (2012) 1.11
Tuberous sclerosis associated neuropsychiatric disorders (TAND) and the TAND Checklist. Pediatr Neurol (2014) 1.11
Targeted treatments for cognitive and neurodevelopmental disorders in tuberous sclerosis complex. Neurotherapeutics (2010) 1.08
Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev (2011) 1.08
Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res (2000) 1.08
GABAergic interneuron development and function is modulated by the Tsc1 gene. Cereb Cortex (2011) 1.07
Epilepsy and autism: is there a special relationship? Epilepsy Behav (2012) 1.06
Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol Dis (2012) 1.05
Tailoring mTOR-based therapy: molecular evidence and clinical challenges. Pharmacogenomics (2013) 1.05
Early developmental trajectories associated with ASD in infants with tuberous sclerosis complex. Neurology (2014) 1.04
Autism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses. Front Mol Neurosci (2013) 1.04
Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex. Neurobiol Dis (2011) 1.03
Infantile spasms in tuberous sclerosis complex: prognostic utility of EEG. Epilepsia (2008) 1.01
Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J Neurosci (2014) 1.01
Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex. Eur J Paediatr Neurol (2013) 0.99
Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav Genet (2010) 0.98
Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders. Cereb Cortex (2012) 0.97
Focal malformations of cortical development: new vistas for molecular pathogenesis. Neuroscience (2013) 0.97
Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option? Eur J Paediatr Neurol (2013) 0.97
A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits. Int J Dev Neurosci (2013) 0.96
An overview of the mTOR pathway as a target in cancer therapy. Expert Opin Ther Targets (2012) 0.95
Tuberous sclerosis. Handb Clin Neurol (2013) 0.94
Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. Hum Mol Genet (2012) 0.92
Diffusion tensor imaging and related techniques in tuberous sclerosis complex: review and future directions. Future Neurol (2013) 0.91
Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Int J Dev Neurosci (2014) 0.90
Temporal and mosaic Tsc1 deletion in the developing thalamus disrupts thalamocortical circuitry, neural function, and behavior. Neuron (2013) 0.90
Neuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1. Hum Mol Genet (2014) 0.90
From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches. Neuropharmacology (2012) 0.88
Clinical characteristics of children and young adults with co-occurring autism spectrum disorder and epilepsy. Epilepsy Behav (2015) 0.88
Rapamycin has a beneficial effect on controlling epilepsy in children with tuberous sclerosis complex: results of 7 children from a cohort of 86. Childs Nerv Syst (2013) 0.88
Advances in the treatment of tuberous sclerosis complex. Curr Opin Psychiatry (2015) 0.87
Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders. Sci Signal (2014) 0.86
Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex. PLoS One (2013) 0.86
Mechanism of action of vigabatrin: correcting misperceptions. Acta Neurol Scand Suppl (2011) 0.84
Behavioral signatures related to genetic disorders in autism. Mol Autism (2014) 0.84
EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients. Eur J Paediatr Neurol (2013) 0.84
Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models. Dis Model Mech (2013) 0.80
Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science (2008) 6.86
Loss of the tuberous sclerosis complex tumor suppressors triggers the unfolded protein response to regulate insulin signaling and apoptosis. Mol Cell (2008) 3.91
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci (2008) 3.64
A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci (2007) 3.51
Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 Iinternational Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol (2013) 3.49
S6K1 regulates GSK3 under conditions of mTOR-dependent feedback inhibition of Akt. Mol Cell (2006) 3.25
Somatic mutations in cerebral cortical malformations. N Engl J Med (2014) 3.13
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature (2012) 3.12
ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc Natl Acad Sci U S A (2010) 3.03
The tower of Babel: survey on concepts and terminology in electrical status epilepticus in sleep and continuous spikes and waves during sleep in North America. Epilepsia (2012) 2.73
Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron (2005) 2.72
Tuberous sclerosis complex proteins control axon formation. Genes Dev (2008) 2.33
Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nat Neurosci (2006) 2.30
Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci (2010) 2.17
A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagy in response to ROS. Nat Cell Biol (2013) 1.96
Human CHN1 mutations hyperactivate alpha2-chimaerin and cause Duane's retraction syndrome. Science (2008) 1.84
EphB-mediated degradation of the RhoA GEF Ephexin5 relieves a developmental brake on excitatory synapse formation. Cell (2010) 1.82
Percutaneous treatment of liver hydatid cysts: comparison of direct injection of albendazole and hypertonic saline solution. AJR Am J Roentgenol (2005) 1.79
Incisional hernia rate may increase after single-port cholecystectomy. J Laparoendosc Adv Surg Tech A (2012) 1.75
Everolimus alters white matter diffusion in tuberous sclerosis complex. Neurology (2012) 1.73
Copy number variation plays an important role in clinical epilepsy. Ann Neurol (2014) 1.73
Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci (2009) 1.67
Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex. Proc Natl Acad Sci U S A (2011) 1.58
Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol (2007) 1.54
MicroRNA profiling reveals two distinct p53-related human pluripotent stem cell states. Cell Stem Cell (2010) 1.49
Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron (2005) 1.44
Long-term response to high-dose diazepam treatment in continuous spikes and waves during sleep. Pediatr Neurol (2013) 1.41
Potential benefits of hyperbaric oxygen therapy on atherosclerosis and glycaemic control in patients with diabetic foot. Endokrynol Pol (2010) 1.41
Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc Natl Acad Sci U S A (2011) 1.32
TSC1/TSC2 signaling in the CNS. FEBS Lett (2011) 1.31
Surgical treatment of sacrococcygeal pilonidal sinus with the Limberg transposition flap. Surgery (2003) 1.30
Umbilical pilonidal sinus disease: predisposing factors and treatment. World J Surg (2005) 1.28
Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex. Acad Radiol (2012) 1.26
Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol (2011) 1.24
Timing of cholecystectomy for acute biliary pancreatitis: outcomes of cholecystectomy on first admission and after recurrent biliary pancreatitis. World J Surg (2003) 1.22
The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type PPARgamma inhibition. Oncogene (2004) 1.20
Febrile infection-related epilepsy syndrome (FIRES): pathogenesis, treatment, and outcome: a multicenter study on 77 children. Epilepsia (2011) 1.18
Brain functional networks in syndromic and non-syndromic autism: a graph theoretical study of EEG connectivity. BMC Med (2013) 1.17
Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy. Epilepsia (2012) 1.17
Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex. Ann Clin Psychiatry (2011) 1.15
Clinical presentation and diagnosis of tuberous sclerosis complex in infancy. J Child Neurol (2008) 1.14
The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract (2013) 1.14
Diffusion features of white matter in tuberous sclerosis with tractography. Pediatr Neurol (2010) 1.13
Anti-NMDA receptor encephalitis presenting with imaging findings and clinical features mimicking Rasmussen syndrome. Seizure (2010) 1.06
Lymphangioleiomyomatosis screening in women with tuberous sclerosis. Chest (2013) 1.05
Comparison of mechanical bowel obstruction cases of intra-abdominal tumor and non-tumoral origin. World J Surg (2006) 1.05
Maximum a posteriori estimation of isotropic high-resolution volumetric MRI from orthogonal thick-slice scans. Med Image Comput Comput Assist Interv (2010) 1.02
A mathematical framework for the registration and analysis of multi-fascicle models for population studies of the brain microstructure. IEEE Trans Med Imaging (2013) 1.02
Continuous spike and waves during sleep and electrical status epilepticus in sleep. J Clin Neurophysiol (2011) 1.00
Spontaneous biloma managed with endoscopic retrograde cholangiopancreatography and percutaneous drainage: a case report. J Med Case Rep (2011) 1.00
Autism and the synapse: emerging mechanisms and mechanism-based therapies. Curr Opin Neurol (2015) 0.98
Registration and analysis of white matter group differences with a multi-fiber model. Med Image Comput Comput Assist Interv (2012) 0.98
Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders. Cereb Cortex (2012) 0.97
Endothelial cell-fatty acid binding protein 4 promotes angiogenesis: role of stem cell factor/c-kit pathway. Angiogenesis (2012) 0.97
Interdigital pilonidal sinus: a case report and literature review. Dermatol Surg (2012) 0.96
NMDA mediated contextual conditioning changes miRNA expression. PLoS One (2011) 0.96
[A case of Rapunzel syndrome]. Ulus Travma Acil Cerrahi Derg (2004) 0.95
A brain symmetry index (BSI) for online EEG monitoring in carotid endarterectomy. Clin Neurophysiol (2004) 0.95
Endoscopic retrograde cholangiopancreatography during pregnancy without radiation. World J Gastroenterol (2009) 0.95
Solitary juxtacortical neurofibroma of the humerus. Skeletal Radiol (2001) 0.94
Graded loss of tuberin in an allelic series of brain models of TSC correlates with survival, and biochemical, histological and behavioral features. Hum Mol Genet (2012) 0.92
Management of lactational breast abscesses. Breast (2005) 0.92
Electrical status epilepticus in sleep: clinical presentation and pathophysiology. Pediatr Neurol (2012) 0.92
Clinical staging and electroencephalographic evolution of continuous spikes and waves during sleep. Epilepsia (2012) 0.92
Acute appendicitis during pregnancy. Dig Surg (2002) 0.91
Short-term response of sleep-potentiated spiking to high-dose diazepam in electric status epilepticus during sleep. Pediatr Neurol (2012) 0.90
Atypical face processing in children with tuberous sclerosis complex. J Child Neurol (2012) 0.90
SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress. Cell Mol Neurobiol (2011) 0.90
Which repair in umbilical hernia of adults: primary or mesh? Int Surg (2006) 0.89
Vigabatrin for childhood partial-onset epilepsies. Pediatr Neurol (2012) 0.89
Spinal cord involvement in a child with raccoon roundworm (Baylisascaris procyonis) meningoencephalitis. Pediatr Radiol (2011) 0.89
Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Acta Diabetol (2007) 0.88
Effect of laparoscopic cholecystectomy techniques on postoperative pain: a prospective randomized study. J Korean Surg Soc (2013) 0.87
Severe hypertriglyceridemia-induced pancreatitis during pregnancy. J Natl Med Assoc (2006) 0.87
Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis (2009) 0.87
Preoperative detection of insulinomas: two case reports. Cases J (2008) 0.87
RASA1 functions in EPHB4 signaling pathway to suppress endothelial mTORC1 activity. J Clin Invest (2014) 0.87
SNP discovery by illumina-based transcriptome sequencing of the olive and the genetic characterization of Turkish olive genotypes revealed by AFLP, SSR and SNP markers. PLoS One (2013) 0.86
A genetic model to dissect the role of Tsc-mTORC1 in neuronal cultures. Methods Mol Biol (2012) 0.86
Febrile infection-related epilepsy syndrome (FIRES): does duration of anesthesia affect outcome? Epilepsia (2011) 0.86
Neurofibroma adjacent to the thyroid gland and a thyroid papillary carcinoma in a patient with neurofibromatosis type 1: report of a case. Surg Today (2009) 0.86
Translational research: Rett syndrome and tuberous sclerosis complex. Curr Opin Pediatr (2011) 0.85
Obesity and obstructive sleep apnea syndrome. J Otolaryngol Head Neck Surg (2010) 0.85
Electrode localization for planning surgical resection of the epileptogenic zone in pediatric epilepsy. Int J Comput Assist Radiol Surg (2013) 0.84
The effects of different hernia repair methods on postoperative pain medication and CRP levels. Surg Laparosc Endosc Percutan Tech (2002) 0.84
Comparison of surgical techniques for treatment of benign toxic multinodular goiter. World J Surg (2005) 0.84
Induction and assessment methods used in experimental adhesion studies. Wound Repair Regen (2005) 0.84
Neonatal subependymal giant cell astrocytoma: new case and review of literature. Pediatr Neurol (2007) 0.84
EphA7 signaling guides cortical dendritic development and spine maturation. Proc Natl Acad Sci U S A (2014) 0.84
Needle-free delivery of lidocaine for reducing the pain associated with the fine-needle aspiration biopsy of thyroid nodules: time-saving and efficacious procedure. Thyroid (2007) 0.84
Tuberculosis of the breast. Breast J (2005) 0.83
Three-dimensional MR and axial CT colonography versus conventional colonoscopy for detection of colon pathologies. World J Gastroenterol (2006) 0.83
Lower leptin levels in young non-obese male smokers than non-smokers. Ups J Med Sci (2009) 0.83
Effects of gender on the severity of sepsis. Surg Today (2005) 0.83
[Complicated Meckel's diverticulum]. Ulus Travma Acil Cerrahi Derg (2003) 0.82
The role of dura mater and free peritoneal graft in the reinforcement of colon anastomosis. J Invest Surg (2007) 0.82
Association between antibodies against calcifying nanoparticles and mitral annular calcification. J Heart Valve Dis (2010) 0.82
Deletion of chromosome 1p36 is associated with periventricular nodular heterotopia. Am J Med Genet A (2006) 0.82